ICTUS Study: International Citicoline Trial on Acute Stroke

This study has been terminated.
(With 2078 patients, a statistical stopping boundary has now been crossed)
Sponsor:
Information provided by (Responsible Party):
Ferrer Internacional S.A.
ClinicalTrials.gov Identifier:
NCT00331890
First received: May 30, 2006
Last updated: June 19, 2012
Last verified: June 2012